Submissions for variant NM_138694.4(PKHD1):c.5912G>A (p.Gly1971Asp)

gnomAD frequency: 0.00006  dbSNP: rs180675584

Total submissions: 8

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics	RCV000440845	SCV000511619	pathogenic	not provided	2017-01-06	criteria provided, single submitter	clinical testing
Blueprint Genetics	RCV000440845	SCV000927917	likely pathogenic	not provided	2018-09-05	criteria provided, single submitter	clinical testing
Baylor Genetics	RCV001004198	SCV001163037	pathogenic	Autosomal recessive polycystic kidney disease		criteria provided, single submitter	clinical testing
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology	RCV001775118	SCV002012479	likely pathogenic	Polycystic kidney disease 4	2014-10-13	criteria provided, single submitter	research	ACMG codes: PM2; PM3; PP3; PP5
GeneDx	RCV000440845	SCV002030916	likely pathogenic	not provided	2023-01-17	criteria provided, single submitter	clinical testing	Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 25263802, 14741187, 12874454, 22034641, 15805161)
Invitae	RCV001004198	SCV002208061	pathogenic	Autosomal recessive polycystic kidney disease	2024-01-17	criteria provided, single submitter	clinical testing	This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 1971 of the PKHD1 protein (p.Gly1971Asp). This variant is present in population databases (rs180675584, gnomAD 0.009%). This missense change has been observed in individuals with polycystic kidney disease (PMID: 12874454, 19940839). ClinVar contains an entry for this variant (Variation ID: 377269). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PKHD1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics	RCV001775118	SCV004204618	pathogenic	Polycystic kidney disease 4	2023-07-02	criteria provided, single submitter	clinical testing
Sydney Genome Diagnostics, Children's Hospital Westmead	RCV001004198	SCV001449399	likely pathogenic	Autosomal recessive polycystic kidney disease	2018-05-22	no assertion criteria provided	clinical testing	This individual is heterozygous for the c.5912G>A variant in the PKHD1 gene. This variant has been previously reported in patients with autosomal recessive polycystic kidney disease either in the homozygous form or compound heterozygous with a second pathogenic PKHD1 variant (Sharp et al J Med Genet 2005; 42:336-349; Bergmann et al 2011 J Am Soc Nephrol 22: 2047-2056). This variant has been reported in the gnomAD browser (http://gnomad.broadinstitute.org) with a low allele frequency of 0.004% (12/ 276, 768 alleles). In silico analysis of pathogenicity (through Alamut Visual v2.8.1) using PolyPhen2, SIFT and MutationTaster suggest that this variant is likely to be pathogenic. This variant is considered to be likely pathogenic according to the ACMG guidelines.